You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Hers
since
auto-detected in 47 stories
34 days ago
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
Stocks making the biggest moves after hours: Hims & Hers, Gitlab, Cleanspark, Webtoon Entertainment & more ⊕
See which stocks are posting big moves after the bell.
51 days ago
Stocks making the biggest moves midday: Intel, AMD, Charter, Hims & Hers, Eli Lilly and more ○
These are the stocks posting the largest moves in midday trading.
82 days ago
EDEN CONFIDENTIAL: JCB heiress Alice Bamford grieves partner Ann in emotional tribute ○
Hers has always been a gilded existence, but Alice, 49, never made the mistake of thinking she was invulnerable to the cruel luck that can strike anyone.
3 months ago
Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more ○
found
These are some of the stocks seeing the largest midday moves.
Stocks making the biggest moves midday: Chevron, Hims and Hers, Xenon Pharma, Vertiv and more ○
These are some of the stocks posting the largest midday moves.
Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs ⊖
Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.
Stocks making the biggest moves premarket: Walmart, Hims & Hers, Carvana, Figma & more ○
These are the stocks posting the largest moves in the premarket.
Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion ⊕
found
The deal would give Hims & Hers a foothold in Australia and Japan while deepening its presence in the United Kingdom, Germany, and Canada.
4 months ago
Wegovy maker sues rival over 'knock-off' weight-loss drugs ⊖
Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".